Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 78 results for "lacosamide"

Claim term is construed in lacosamide ANDA case.

UCB, Inc., et al. v. Accord Healthcare, Inc. et al , C.A. No. 13-1206 LPS, May 14, 2015 Stark, C.J. Claim construction ruling issues on one term from the patent-in-suit. Multimedia technology tutorials had been submitted, and a claim construction ... Lexology, 2 days ago

1 images for "lacosamide"

MDLinx, 3 weeks ago
India Infoline

Alembic Pharma gains on buzz of getting USFDA nod

Media reports said that the company has got tentative US FDA nod for Epilepsy drug Lacosamide.
 India Infoline3 weeks ago 3/22/15 - India,United States : AUROBINDO PHARMA gets FDA approval for LACOSAMIDE TABLETS [TendersInfo (India)]  Pharmacy Choice2 months ago Aurobindo Pharma receives USFDA Tentative Approval for Lacosamide Tablets  Equity Bulls2 months ago Aurobindo gets tentative nod from USFDA for Lacosamide tablets  ZeeNews.com2 months ago
[x]  
India Infoline

Aurobindo Pharma stock ends 1% lower after hitting record high

Lacosamide Tablets are the generic equivalent of USB Inc’s Vimpat Tablets and used in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older with a market size of approximately US$ 593 Million for the twelve months ending ...
 India Infoline2 months ago Aurobindo Pharma receives US FDA tentative approval for Lacosamide tabs  Financial Express2 months ago Aurobindo gets tentative US FDA nod for Lacosamide tablets  Smart Investor2 months ago Aurobindo gets US FDA nod for Lacosamide tablets  Hindu Business Line2 months ago
[x]  
Business Standard

Aurobindo Pharma hits record high on USFDA tentative nod for Lacosamide tablets

Related to : Aurobindo Pharma Ltd Aurobindo Pharma Ltd BSE 19 Mar 15 | 03:05 PM 1239.30 -3.05 (-0.25%) NSE 19 Mar 15 | 02:54 PM 1251.00 6.05 (0.49%) Shares of Aurobindo Pharma were trading higher by 2% at Rs 1,265 on the BSE ...
 Smart Investor2 months ago Equity Report By Ways2Capital 23 March 2015  Press Release Ping2 months ago
[x]  

New and Generic Drug Approvals: Lacosamide

LACOSAMIDE LACOSAMIDE 50MG TABLET;ORAL None (Tentative Approval) No None LACOSAMIDE ...
 U.S. Food and Drug Administration3 weeks ago

Patent Issued for Indanesulfamide Derivatives

By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia , NewsRx journalists report that a patent by the inventors Kazuta, Yuji (Tsukuba, JP); Watanabe, Toru (Tsukuba, JP); Sorimachi, Keiichi (Tsukuba, JP); Saito, Minako ...
 4 Traders3 weeks ago

Meeting summaries: Alzheimer disease, epilepsy, MS, stroke

American Academy of Neurology Washington, April 1825, 2015 ( www.aan.com ) Alzheimer disease Results of a multicenter, double-blind, two-stage, 10-week study showed that patients with probable Alzheimer disease and clinically meaningful ...
 Pharmacist.com3 weeks ago

CMS spent $103 billion on Medicare Part D in 2013, $2.5 billion on Nexium

CMS spent $2.5 billion on the heartburn drug in 2013 on 8.2 million claims. Henry Powderly, Managing Editor The Center for Medicare and Medicaid Services spent more than $103 billion on prescription drugs in 2013 under the Medicare Part D ...
 Healthcare Finance News3 weeks ago
Medical News Today

Important UCB presence at the 2015 American Academy of Neurology Meeting

/PRNewswire/ --UCB, a global biopharmaceutical company focusing on neurology and immunology treatment and research, is sponsoring a total of 24 data presentations at the 67th Annual Meeting of the American Academy of Neurology (AAN) in Washington, ...
 Crawford Financial Planning1 month ago What is neuropathy? Neuropathy causes and treatments  Medical News Today1 month ago
[x]  

Sunovion Pharmaceuticals Inc. to Present Data on Aptiom® (eslicarbazepine acetate) at 67th American Academy of Neurology Annual Meeting

MARLBOROUGH, Mass.--( BUSINESS WIRE )--Sunovion Pharmaceuticals Inc. (Sunovion) will present five research posters at the 67 th American Academy of Neurology (AAN) Annual Meeting (April 18-25, Washington, D.C.), including findings from ...
 Business Wire1 month ago Sunovion Pharmaceuticals Inc. : to Present Data on Aptiom® (eslicarbazepine acetate) at 67th American Academy of Neurology Annual Meeting  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lacosamide
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less